Growth phase-dependent expression of ICAD-L/DFF45 modulates the pattern of apoptosis in human colonic cancer cells1

Cancer Research

Volumn 62, Issue 7, 2002, Pages 2169-2174

  Charrier, Laetitia ^a   Jarry, Anne ^a   Toquet, Claire ^a   Bou Hanna, Chantal ^a   Chedorge, Marie ^a   Denis, Marc ^a   Vallette, Geneviève ^a   Laboisse, Christian L ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3 INHIBITOR; CYTOKERATIN 18; DEOXYRIBONUCLEASE; DOXORUBICIN; INHIBITOR OF APOPTOSIS PROTEIN;

ALTERNATIVE RNA SPLICING; APOPTOSIS; ARTICLE; CANCER CELL; CANCER GROWTH; CELL DEATH; CLONAL VARIATION; COLON CANCER; ENZYME ACTIVATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR BINDING; RECEPTOR DOWN REGULATION; SIGNAL TRANSDUCTION; TARGET CELL;

APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CACO-2 CELLS; CELL DIVISION; CELL NUCLEUS; COLON; COLONIC NEOPLASMS; HT29 CELLS; HUMANS; PROTEIN BIOSYNTHESIS; PROTEINS; TUMOR CELLS, CULTURED;

EID: 0036532162     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Caspases: The executioners of apoptosis
2. Apoptosis and the dilemma of cancer chemotherapy
3. Induction of apoptosis by cancer chemotherapy
4. Caspase-activated DNase that degrades DNA during apoptosis and its inhibitor ICAD
5. Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis
6. CPAN, a human nuclease regulated by the caspase-sensitive inhibitor ICAD
7. DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis
8. Molecular cloning and characterization of human caspase-activated DNase
9. Identification of regulatory and catalytic domains in the apoptosis nuclease DFF40/CAD
10. Functional interaction of DFF35 and DFF45 with caspase-activated DNA fragmentation nuclease DFF40
11. DNA fragmentation factor 45-deficient cells are more resistant to apoptosis and exhibit different dying morphology than wild-type control cells
12. New human tumor cell lines
13. Emergence of permanently differentiated cell clones in a human colonic cancer cell line in culture after treatment with sodium butyrate
14. Overexpression of ras in mucus-secreting human colon carcinoma cells of low tumorigenicity
15. - movements in human colonic epithelial cells (HT29-C1.16E)
16. Interferon-γ modulates cAMP-induced mucin exocytosis without affecting mucin gene expression in a human colonic goblet cell line
17. - channels from granule membrane to plasma membrane
18. Characterization of a newly established human gastric cancer cell line HGT-1 bearing histamine H2-receptors
19. Early functional effects of Clostridium difficile toxin A on human colonocytes
20. Nitric oxide inhibits apoptosis by preventing increases in caspase-3-like activity via two distinct mechanisms
21. Immunocytochemical detection and mapping of a cytokeratin 18 neo-epitope exposed during early apoptosis
22. Caspase-3 is the primary activator of apoptotic DNA fragmentation via DNA fragmentation factor-45/inhibitor of caspase-activated DNase inactivation
23. Caspase cleavage of keratin 18 and reorganization of intermediate filaments during epithelial cell apoptosis
24. Colon carcinoma cells use different mechanisms to escape CD95-mediated apoptosis
25. CD95 (APO-1/Fas)-mediated apoptosis in colon epithelial cells: A possible role in ulcerative colitis
26. Resistance to apoptosis correlates with a highly proliferative phenotype and loss of Fas and CPP32 (caspase-3) expression in human leukemia cells
27. Induction of the synthesis of tumor necrosis factor receptors by interferon-γ
28. Divergent induction of apoptosis and IL-8 secretion in HT-29 cells in response to TNF-α and ligation of Fas antigen
29. Interferon-γ modulates a p53-independent apoptotic pathway and apoptosis-related gene expression
30. Involvement of the CD95 (APO-1/FAS) receptor/ligand system in drug-induced apoptosis in leukemia cells
31. The CD95 (APO-1/Fas) system mediates drug-induced apoptosis in neuroblastoma cells
32. STAT-1-independent upregulation of FADD and procaspase-3 and -8 in cancer cells treated with cytotoxic drugs
33. Enhancement of Fas-mediated apoptosis in renal cell carcinoma cells by Adriamycin
34. Essential contribution of caspase 3/CPP32 to apoptosis and its associated nuclear changes
35. Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis
36. p53 mutations in colorectal cancer
37. Conserved expression of intestinal trefoil factor in the human colonic adenoma-carcinoma sequence
38. Intestinal trefoil factor confers colonic epithelial resistance to apoptosis